⌕
Anbio Biotechnology · NNNN · Nasdaq
Tenet 37 · Weak
Compare
$3.65−5.93%At closeTenet 37 · Weak
$3.65−0.23 (−5.93%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Anbio Biotechnology (NNNN) Stock Checks

How NNNN measures up against value, income, timing, and long-hold tenets. Every criterion shows the number as of the last close and the pass rule. Always free.

Sources Company filings and computed by Tenet Filings and TenetScreens as of How we compute thisNot investment advice

The tenets below and the 0-100 Tenet Score on this report are two separate computations: each tenet runs its own criteria and its own pass rule, while the score is a percentile composite reported as one of four verdict words (Strong, Solid, Mixed or Weak).

1 / 17 qualify todayas of close, Nov 16, 2026 · computed nightly from our fundamentals DB; point-in-time auditable.
QUALIFIES
1
meet every gate today
BORDERLINE
3
within one input of the gate
FAILS
9
miss at least one gate
UNKNOWN
4
insufficient data to judge
Buffett Qualitydurable moat
~ Borderline
PassesROE ≥ 15%27.0% · ≥ 15.0%
Unknown — no dataGross margin ≥ 40%— · ≥ 40.0%
Unknown — no dataNet margin ≥ 15%— · ≥ 15.0%
PassesDebt/equity ≤ 0.50.00 · ≤ 0.50
FailsGrowing FCF (multi-yr)Free cash flow was negative in fiscal 2025.no · > 0
Decided by the pass rule for Buffett Quality.
The pass rule for Buffett Quality is what decides that verdict, and it is not restated here. 2 of 5 carry no data.Buffett Quality under The screens ›Today's Buffett Quality list ›
PassesReturn on assets positive21.2% · > 0
FailsOperating cash flow positive−$6.7M · > 0
PassesReturn on assets improving12.5% → 21.2%
FailsEarnings backed by cash (CFO > net income)−$6.7M vs $6.4M
FailsLeverage falling (long-term debt / assets)We hold no record of long-term debt as a share of assets for both years for this company, so this signal could not be measured. It still scores 0 under this module's conservative rule (a point is never awarded without evidence), and it is not counted as one of the signals we were able to measure.no
PassesCurrent ratio improving10.71 → 344.31
PassesNo share dilution (≤ +2%)+1.1%
PassesGross margin expanding71.9% → 87.2%
FailsAsset turnover improving0.43 → 0.29
Decided by the pass rule for Piotroski F-Score.
The pass rule for Piotroski F-Score is what decides that verdict, and it is not restated here. 1 of 9 carry no data.Piotroski F-Score under The screens ›Today's Piotroski F-Score list ›
PassesROIC ≥ 15%19.1% · ≥ 15.0%
PassesNet debt/EBITDA ≤ 3×−2.1× · ≤ 3.0×
Unknown — no dataAltman Z ≥ 3 (safe zone)— · ≥ 3.00
Decided by the pass rule for Munger Compounders.
The pass rule for Munger Compounders is what decides that verdict, and it is not restated here. 1 of 3 carry no data.Munger Compounders under The screens ›Today's Munger Compounders list ›
PassesEBIT > 0$5.8M · > 0
FailsEarnings yield EBIT/EV ≥ 6%1.1% · ≥ 6.0%
FailsReturn on capital ≥ 25%19.1% · ≥ 25.0%
Decided by the pass rule for Magic Formula.
The pass rule for Magic Formula is what decides that verdict, and it is not published separately on the methodology page.About this screen ›Today's Magic Formula® list ›
FailsSize: market cap ≥ $2B$558.3M · ≥ $2.0B
Unknown — no dataCurrent ratio ≥ 2— · ≥ 2.00
PassesPositive EPS 4y4y
FailsPays a dividend$0.00 · > 0
Unknown — no dataEPS growth ≥ 3%/yr— · ≥ 3.0%
FailsP/E ≤ 1587.19 · ≤ 15.00
FailsP/E × P/B ≤ 22.51,614.20 · ≤ 22.50
Decided by the pass rule for Graham Defensive.
The pass rule for Graham Defensive is what decides that verdict, and it is not restated here. 2 of 7 carry no data.Graham Defensive under The screens ›Today's Graham Defensive list ›
Unknown — no dataPEG < 1 (hist. growth)— · < 1.00
Unknown — no dataEPS growth 10–30%— · 10.0%–30.0%
Verdict Unknown for this set.
Verdict Unknown for this set. None of the 2 checks below carry data.Lynch GARP under The screens ›Today's Lynch GARP list ›
FailsPays a dividend$0.00 · > 0
Unknown — no dataYield in a healthy band (not a yield trap)0.0% · 1.0%–8.0%
Unknown — no dataCovered by free cash flow— · ≥ 1.20
Unknown — no dataEarnings payout not stretched— · ≤ 75.0%
Unknown — no dataBalance sheet can sustain the payout−2.1× · ≤ 4.0×
Verdict Unknown for this set.
Verdict Unknown for this set. 1 of 5 checks below carry data. The pass rule for Income & Dividend Safety is not published separately on the methodology page.
FailsPays a dividend$0.00 · > 0
Unknown — no dataAnnual dividend raised 10+ years running (Aristocrat ≥25, King ≥50)— · ≥ 10.00
Unknown — no dataNo dividend cut in the last 5 years—
Unknown — no data5-year dividend growth ≥ 5%/yr— · ≥ 5.0%
Unknown — no dataCovered by free cash flow— · ≥ 1.20
Unknown — no dataPayout not stretched— · ≤ 75.0%
Verdict Unknown for this set.
Verdict Unknown for this set. 1 of 6 checks below carry data.Dividend Growth under The screens ›Today's Dividend Growth list ›
FailsReturn on invested capital ≥ 15% in 4+ of the last 5 years1 of 3 on file
FailsRevenue compounding ≥ 8%/yr over 5 years−28.4% · ≥ 8.0%
Not scored: see the reason belowNot diluting: diluted share count flat-to-down (≤ +1%/yr)Not enough clean diluted-share-count history to measure dilution.— · ≤ 1.0%
Not scored: see the reason belowFree cash flow margin ≥ 12%Free-cash-flow margin isn't derivable yet from the statements we have on file.— · ≥ 12.0%
FailsEarnings backed by cash (operating cash flow ≥ net income)−1.05 · ≥ 1.00
Reading: no data. Not a gate checkDisciplined buybacks: actively reducing the share count (bonus)reading, not a gate checkNot enough clean diluted-share-count history to assess buybacks.—
Decided by the pass rule for Quality Compounder.
The pass rule for Quality Compounder is what decides that verdict, and it is not restated here. 2 of 5 carry no data. Lines marked as readings are published beside the checks and are not gate checks.Quality Compounder under The screens ›Today's Quality Compounder list ›
FailsOff its 52-week high by 8–35% (a dip, not a collapse)91.3% · 8.0%–35.0%
FailsDip within its own normal pullback band0.91
FailsNot past where its dips have historically recovered from3.26
FailsA dip in an uptrend (above a rising 200-day)16.03
FailsHigher-low structure still intactstructure broken · higher low
Unknown — no dataClear of the earnings blackout (more than 5 days out)— · > 5.00
Decided by the pass rule for Drawdown Context.
The pass rule for Drawdown Context is what decides that verdict, and it is not published separately on the methodology page. 1 of 6 carry no data.
FailsA bullish MACD cross within 10 sessions16.00 · ≤ 10.00
FailsReclaimed a rising 50-day EMA5.11
PassesPrinted a higher lowyes
FailsA volume thrust on the turn (≥ 1.2× normal)0.81 · ≥ 1.20
FailsReversal signals fired: 3 of 4 (MACD·MA·HL·Vol)1.00 · ≥ 3.00
Decided by the pass rule for Reversal Evidence.
The pass rule for Reversal Evidence is what decides that verdict, and it is not published separately on the methodology page.
Unknown — no dataIn the cheap half of its own 5-year valuation range—
Not scored: see the reason belowEarnings estimates not being cutNo analyst estimate revisions are on file for this company yet, so there is nothing to read a trend from.—
PassesReturns on capital not deteriorating0.19
Verdict Unknown for this set.
Verdict Unknown for this set. 1 of 3 checks below carry data. The pass rule for Not-a-Value-Trap Gate is not published separately on the methodology page.
PassesOperating profit is positive$5.8M · > 0
PassesReturn on invested capital ≥ 10%19.1% · ≥ 10.0%
Not scored: see the reason belowA solvent balance sheet (Altman Z ≥ 1.8, net debt/EBITDA ≤ 4)The Altman Z-score isn't derivable from the statements we have on file, so this two-part test is left unscored.—
PassesQuality score ≥ 5057.20 · ≥ 50.00
FailsRevenue growing over 5 years−28.4% · > 0
Decided by the pass rule for Quality Floor.
The pass rule for Quality Floor is what decides that verdict, and it is not published separately on the methodology page. 1 of 5 carry no data.
A research signal from published criteria, not a recommendation.
FailsDrawdown context91.3% off its 52-week high
FailsReversal evidence1 of 4 signals fired
Unknown — no dataTrap gate1 of 3 held · 2 no data
FailsQuality floor3 of 5 held · 1 no data
Invalidation level (structure break): below this the dip's structure has broken$25.07
Decided by the pass rule for Qualified Dip.
The pass rule for Qualified Dip is what decides that verdict, and it is not restated here. 1 of 4 carry no data.Qualified Dip under The screens ›Today's Qualified Dip list ›
FailsTrading above its 50-day average4.70
FailsTrading above its 200-day average16.03
Fails50-day average above the 200-day (uptrend stack)4.70
Fails50-day average sloping up−0.29 · > 0
Decided by the pass rule for Trend Alignment.
The pass rule for Trend Alignment is what decides that verdict, and it is not published separately on the methodology page.
Fails3-month return in the top half of the universe0.02 · ≥ 0.50
Fails12-minus-1 momentum in the top half of the universe0.00 · ≥ 0.50
FailsRelative strength vs the S&P 500 improving−0.01 · > 0
Not scored: see the reason belowEarnings estimates being revised upNo analyst estimate revisions are on file for this company yet, so there is nothing to read a trend from.—
Decided by the pass rule for Relative Strength.
The pass rule for Relative Strength is what decides that verdict, and it is not published separately on the methodology page. 1 of 4 carry no data.
PassesMACD above its signal line−0.24
FailsBack above the 50-day on a fresh cross (≤10 sessions)16.00
PassesHigher high and higher low (stair-stepping up)higher high · higher low
FailsA volume thrust on the move (≥ 1.2× normal)0.81 · ≥ 1.20
Decided by the pass rule for Momentum Trigger.
The pass rule for Momentum Trigger is what decides that verdict, and it is not published separately on the methodology page.
Average daily swing: high0.11
Volatility band width: squeezed (compressed range)0.05
Distance from its 52-week high: a deep pullback0.91
Every verdict is auditableEach criterion shows the number as of the last close and the pass rule side by side: a receipt, not a rating. Several of these screens publish their rule in full under The screens; each row links to its own section where there is one.
Unknown ≠ failAn “— Unknown” verdict means the inputs were insufficient: context, not a signal, and never counted as a fail.

How many investing rule sets does Anbio Biotechnology pass?

Anbio Biotechnology qualifies on 1 of 17 rule sets as of 2026-11-16, with 3 borderline and 9 failing.

Does Anbio Biotechnology meet the Graham Defensive criteria?

Anbio Biotechnology fails the Graham Defensive rule set as of 2026-11-16.

Does Anbio Biotechnology meet the Buffett Quality criteria?

Anbio Biotechnology is borderline on the Buffett Quality rule set as of 2026-11-16.

Computed from our fundamentals DB; historical-CAGR PEG basis for Lynch. Research, not investment advice. Tenet's rulesets are independently developed from publicly available sources, and Tenet is not affiliated with, sponsored by, endorsed by or otherwise associated with any referenced investor or trademark owner. Full notice. MAGIC FORMULA is a trademark of MagicFormulaInvesting.com LLC.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.